M Stuhec1, J Keuschler2, J Serra-Mestres3, M Isetta3. 1. Department for clinical pharmacy, Ormoz psychiatric hospital, Ormoz, Slovenia; Faculty of pharmacy, University of Ljubljana, Ljubljana, Slovenia. Electronic address: matejstuhec@gmail.com. 2. Faculty of pharmacy, University of Ljubljana, Ljubljana, Slovenia. 3. Central and North West London NHS Foundation Trust, London, UK.
Abstract
BACKGROUND: Chronic hypertension has been associated with an increased risk of cognitive decline. Although a link between hypertension and cognitive decline has been established, there is less evidence supported by systematic reviews. The main aim was to compare different antihypertensive drug groups in relation to their effect on cognition in older patients without established dementia using a systematic review. METHOD: A systematic search in Medline and Embase through to January 2017 was used to identify randomized controlled clinical trials (RCTs) studying the impact of different antihypertensives on cognition in older patients without dementia. Angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACE-Is), beta-blockers (BBs), diuretics, and calcium channel blockers (CCBs) were included in this review. RESULTS: The systematic search identified 358 studies. The full text of 31 RCTs was reviewed and a total of 15 RCTs were included in the review. Most studies reported an improvement in episodic memory in patients treated with ARBs versus placebo or other types of antihypertensive drugs. No study showed an improvement in cognition in patients who received diuretics, BBs, or CCBs. Heterogeneity was high in most trials (predominantly in the blinding of participants and investigators). CONCLUSION: This review suggests that ARBs can improve cognitive functions in the elderly, especially episodic memory. ACE-Is, diuretics, BBs and CCBs did not seem to improve cognitive function in the elderly but were similarly effective in blood pressure lowering as ARBs.
BACKGROUND: Chronic hypertension has been associated with an increased risk of cognitive decline. Although a link between hypertension and cognitive decline has been established, there is less evidence supported by systematic reviews. The main aim was to compare different antihypertensive drug groups in relation to their effect on cognition in older patients without established dementia using a systematic review. METHOD: A systematic search in Medline and Embase through to January 2017 was used to identify randomized controlled clinical trials (RCTs) studying the impact of different antihypertensives on cognition in older patients without dementia. Angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACE-Is), beta-blockers (BBs), diuretics, and calcium channel blockers (CCBs) were included in this review. RESULTS: The systematic search identified 358 studies. The full text of 31 RCTs was reviewed and a total of 15 RCTs were included in the review. Most studies reported an improvement in episodic memory in patients treated with ARBs versus placebo or other types of antihypertensive drugs. No study showed an improvement in cognition in patients who received diuretics, BBs, or CCBs. Heterogeneity was high in most trials (predominantly in the blinding of participants and investigators). CONCLUSION: This review suggests that ARBs can improve cognitive functions in the elderly, especially episodic memory. ACE-Is, diuretics, BBs and CCBs did not seem to improve cognitive function in the elderly but were similarly effective in blood pressure lowering as ARBs.
Authors: Eric E Smith; Philip Barber; Thalia S Field; Aravind Ganesh; Vladimir Hachinski; David B Hogan; Krista L Lanctôt; M Patrice Lindsay; Mukul Sharma; Richard H Swartz; Zahinoor Ismail; Serge Gauthier; Sandra E Black Journal: Alzheimers Dement (N Y) Date: 2020-11-11
Authors: Sabina Alexandra Cojocariu; Alexandra Maștaleru; Radu Andy Sascău; Cristian Stătescu; Florin Mitu; Maria Magdalena Leon-Constantin Journal: Medicina (Kaunas) Date: 2021-02-09 Impact factor: 2.430
Authors: Leopoldo Antônio Pires; Ana Laura Maciel de Almeida; Marilise de Andrade Paraízo; José Otávio do Amaral Corrêa; Débora Dos Santos Dias; Neimar da Silva Fernandes; Danielle Guedes Andrade Ezequiel; Rogério Baumgratz de Paula; Natália Maria da Silva Fernandes Journal: J Bras Nefrol Date: 2022 Jul-Sep
Authors: Andrew R Zullo; Melissa R Riester; Sebhat Erqou; Wen-Chih Wu; James L Rudolph; Michael A Steinman Journal: Drugs Aging Date: 2020-10 Impact factor: 3.923